PATENT CLAIM ANALYSIS

Application Number: 15922921
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "135100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 7):
The antibody or antigen binding fragment according to  claim 1 , conjugated to a drug moiety or a detectable moiety.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15229336', '15750425', '15908218', '15521514', '15521685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8422658285365852
- 35 USC 102 Novelty (BERT): 0.7944695028657014
- Combined Prediction Score: 0.8374861959694968
- Mean Citation Score: 795.537426
- Max Citation Score: 1009.92474
- Similarity Product: 969.6915226041984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test